Synopsis
This
work investigates the repeatability and reproducibility of total sodium
concentration (TSC) estimates in the human brain. Healthy volunteers were
scanned twice at two different sites using comparable 3D Cones acquisitions,
and region of interest TSC values were compared. Consistent TSC estimates were
observed across repeated scans at different sites, and, for robust multi-site
comparisons, a need was identified for standardisation of non-Cartesian data
reconstruction. These preliminary results provide an initial step in the technical
validation of sodium MRI-derived cancer biomarkers.Purpose
Sodium MRI has the
potential to probe the tumour microenvironment and provide quantitative
biomarkers of treatment response in tumours, based on its sensitivity to cell
viability and tissue microstructure
1,2. For example, total sodium
concentration (TSC) has been shown to be elevated in many tumours
1,3,
and is sensitive to chemotherapy in preclinical experiments
4. If TSC is to have clinical utility as a biomarker in oncology, values should be
repeatable within
a given subject
and comparable across different scanners and sites.
This work presents preliminary results on the repeatability and reproducibility
of TSC values in healthy volunteers, providing an initial step in the technical
validation of sodium MRI-derived biomarkers
5.
Methods
Sodium brain MRI was
performed on two male volunteers (aged 35 and 27) scanned twice at two sites, A
and B. One site used a GE 3 T MR750, and the other a Philips 3 T Achieva, and both
used a
1H/
23Na dual-tuned head coil (RAPID Biomedical
GmbH, Rimpar, Germany). Scan-rescan repeatability was assessed after a short
time outside of the scanner of between 20 and 80 minutes. Inter-site/inter-scanner reproducibility was assessed by performing the above protocol at sites A and B,
up to 3 days apart. The scan protocol consisted of a
1H T
1-weighted
scan, followed by a
23Na 3D Cones
6 acquisition: 4x4x4
mm
3, 60x60x60 matrix, TR=100 ms, TE=0.5 ms, FA=90°, readout=10
ms, 3 averages, 11 minutes, G
max=30
mT/m. 6552 (2184 x 3 averages) readouts were performed at each site,
with an additional 3 dummy acquisitions at site A. 3D Cones images were
reconstructed using k-space density compensation weights
7,8 and the Image
Reconstruction Toolbox
9. Two effective matrix sizes,
m = 250 and 350, were investigated for
the weights calculation, both using an oversampling factor of 4. The same
calibration phantoms (consisting of 4% agar, NaCl concentrations: 40, 80 mM)
were used for all scans, and ROI mean signals in the phantoms were used to
derive TSC maps, after applying a power image noise correction
10.
Manually-defined bilateral ROIs were drawn in cerebrospinal fluid (CSF), grey
matter (GM), white matter (WM) and vitreous humour (VH), pooling all voxels for
a given region. TSC repeatability was assessed using the coefficient of variation
(CoV) of ROI median values for scans 1 and 2; mean repeatability across the
4 ROIs is reported for each subject at each site. Reproducibility was assessed
using the CoV of ROI median values obtained for scan 1 at each site, again
reporting mean values across the 4 ROIs.
Results and discussion
Figure 1 shows example images (subject 1), from each scan at the two
sites, for reconstructions with
m =
250 and 350. For a given
m, images
from site B were noticeably smoother than those from site A, a trend observed
in both subjects. These results suggest that the weights calculation should be
adjusted for each scanner, to prevent excessive smoothing. As images from site
A using
m=350 and from site B using
m=250 were visually most similar, these datasets were
used in the subsequent analysis. TSC maps are shown in Figure 2 (subject 2),
and Figure 3 shows boxplots for each ROI in each subject, for both scans at
both sites. General trends were consistent across all scans, with VH TSC higher
than CSF, and similar values observed in GM and WM; mean±SD TSC for all scans
were 92±11 mM (CSF), 24±6 mM (GM), 25±5 mM (WM) and 115±14 mM (VH).
Precision may be improved
by considering more ROIs or using GM/WM/CSF segmentation; note also that CSF
and VH values are likely to be underestimated due to partial T
1
recovery, and may suffer from pulsation and movement artefacts. Scan-rescan
repeatability CoVs were consistently higher at site A than site B, 11% vs 2%
(subject 1), and 7% vs 2% (subject 2), suggesting TSC measurements are more
repeatable at site B than site A. It is likely that these findings are affected
by differing levels of image artefact and the k-space weights used, with the
generally smoother images from site B yielding higher repeatability.
Inter-site/inter-scanner reproducibility CoVs for scan 1 were 4% and 9% for
subjects 1 and 2, respectively.
Conclusion
Consistent TSC estimates
were observed across repeated scans at different sites with different scanners.
k-space weights are an important consideration when comparing multi-site
non-Cartesian data; this will be investigated in future work, along with
phantom and analytical point spread function analysis accounting for site-specific SNR. These developments will aid the standardisation of the
reconstruction and analysis of sodium images acquired at different sites, in
order to robustly evaluate image quality and quantification.
Acknowledgements
DJM and FR contributed equally to this work, and GJMP and FAG
contributed equally to this work. This is a contribution
from the Cancer Imaging Centre in Cambridge & Manchester, which is
funded
by the EPSRC and Cancer Research UK (C197/A16465 and C8742/A18097).
This work was supported by
the EPSRC (EP/M005909/1). This work was supported by a research
agreement between
Philips Healthcare
and The University of Manchester. The authors acknowledge the
contributions of Christian
Stehning from Philips Research, Hamburg, Germany, Dave Higgins from
Philips Healthcare, UK, and Rolf Schulte from GE Global Research, Munich,
Germany.References
1Ouwerkerk et al.
Radiology. 2003;227:529-537. 2Thulborn et al. Neuroimaging Clin N Am. 2009;19:615-624. 3Ouwerkerk
et al. Breast Cancer Res Treat. 2007;106:151-160.
4Schepkin et al. NMR Biomed. 2006;19:1035-1042. 5Imaging Biomarker
Roadmap for Cancer Studies, www.cancerresearchuk.org/sites/default/files/imaging.pdf.
Accessed November 8th, 2015. 6Gurney et al. Magn Reson Med. 2006;55:575-582. 7Riemer et al. MAGMA. 2014;27:35-46. 8Zwart et al. Magn Reson Med. 2012;67:701-710. 9Fessler and Sutton. IEEE Trans Signal Process. 2003;51:560-574. 10Miller
and Joseph. Magn Reson Imaging. 1993;11:1051-1056.